The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2

被引：4
作者：
Hu, Yuan [1 ]
Liu, Lili [1 ]
Zhang, Shenghua [1 ]
Su, Shaoyu [1 ]
Liang, Xiao [1 ]
机构：
[1] Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects & Related Dis Women & Childr, Dev & Related Dis Women & Children Key Lab Sichuan, Chengdu 610041, Peoples R China
来源：
ACS OMEGA | 2024年 / 9卷 / 05期
关键词：
NEUTRALIZING ANTIBODY-RESPONSES; DRUG-DELIVERY-SYSTEMS; DELTA INULIN; NANOPARTICLE VACCINE; ANTIVIRAL ACTIVITY; POTENT VACCINE; DOUBLE-BLIND; IN-VITRO; T-CELL; ADJUVANT;
D O I：
10.1021/acsomega.3c08326
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The coronavirus disease-19 (COVID-19) pandemic has had a significant impact on human life worldwide since 2019. Specific vaccines and antiviral agents are the most effective means of preventing and treating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Additionally, antiviral protective equipment and early diagnosis also contribute to controlling the spread of COVID-19. The utilization of biomaterials in medicine and pharmaceuticals is crucial to ensure the positive impact of vaccines, antiviral agents, and protective equipment. In this review, we discuss the application of various types of biomaterials, including polymers, lipid nanoparticles, inorganic biomaterials, protein- or peptide-associated biomaterials, self-assembled biomaterials, and other biomaterials, for the vaccine, treatment, and prevention of COVID-19. Finally, we provide a perspective on future opportunities and challenges for developing biomaterials to combat other viral outbreaks and diseases.
引用
收藏
页码：5175 / 5192
页数：18
相关论文
共 220 条
[1]   Lipid polymer hybrid nanocarriers as a combinatory platform for different anti-SARS-CoV-2 drugs supported by computational studies [J].
Abdel-Bar, Hend Mohamed ;
Abdallah, Inas A. ;
Fayed, Marwa A. A. ;
Moatasim, Yassmin ;
Mostafa, Ahmed ;
El-Behairy, Mohammed Farrag ;
Elimam, Hanan ;
Elshaier, Yaseen A. M. M. ;
Abouzid, Khaled A. M. .
RSC ADVANCES, 2021, 11 (46) :28876-28891
[2]   Alginate-coated chitosan nanoparticles act as effective adjuvant for hepatitis A vaccine in mice [J].
AbdelAllah, Nourhan H. ;
Gaber, Yasser ;
Rashed, Mohamed E. ;
Azmy, Ahmed F. ;
Abou-Taleb, Heba A. ;
AbdelGhani, Sameh .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 152 :904-912
[3]   Chitosan and Sodium Alginate Combinations Are Alternative, Efficient, and Safe Natural Adjuvant Systems for Hepatitis B Vaccine in Mouse Model [J].
AbdelAllah, Nourhan H. ;
Abdeltawab, Nourtan F. ;
Boseila, Abeer A. ;
Amin, Magdy A. .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
[4]   Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases [J].
Ai, Tao ;
Yang, Zhenlu ;
Hou, Hongyan ;
Zhan, Chenao ;
Chen, Chong ;
Lv, Wenzhi ;
Tao, Qian ;
Sun, Ziyong ;
Xia, Liming .
RADIOLOGY, 2020, 296 (02) :E32-E40
[5]   Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19 [J].
Ajaz, Saima ;
McPhail, Mark J. ;
Singh, Keshav K. ;
Mujib, Salma ;
Trovato, Francesca M. ;
Napoli, Salvatore ;
Agarwal, Kosh .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2021, 320 (01) :C57-C65
[6]   Liposome: classification, preparation, and applications [J].
Akbarzadeh, Abolfazl ;
Rezaei-Sadabady, Rogaie ;
Davaran, Soodabeh ;
Joo, Sang Woo ;
Zarghami, Nosratollah ;
Hanifehpour, Younes ;
Samiei, Mohammad ;
Kouhi, Mohammad ;
Nejati-Koshki, Kazem .
NANOSCALE RESEARCH LETTERS, 2013, 8
[7]   Hyperspectral Mapping for the Detection of SARS-CoV-2 Using Nanomolecular Probes with Yoctomole Sensitivity [J].
Alafeef, Maha ;
Moitra, Parikshit ;
Dighe, Ketan ;
Pan, Dipanjan .
ACS NANO, 2021, 15 (08) :13742-13758
[8]   Sensing of COVID-19 Antibodies in Seconds via Aerosol Jet Nanoprinted Reduced-Graphene-Oxide-Coated 3D Electrodes [J].
Ali, Md Azahar ;
Hu, Chunshan ;
Jahan, Sanjida ;
Yuan, Bin ;
Saleh, Mohammad Sadeq ;
Ju, Enguo ;
Gao, Shou-Jiang ;
Panat, Rahul .
ADVANCED MATERIALS, 2021, 33 (07)
[9]  
Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
[10]   Liposomal drug delivery systems: From concept to clinical applications [J].
Allen, Theresa M. ;
Cullis, Pieter R. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :36-48
12345678910